On-premise AI for pharmaceutical companies means running language models inside your own network so formulations, process parameters, study data and submission drafts never leave it. The driver is usually trade secret protection and change control rather than privacy alone, which makes it a different decision from a hospital's.
Why pharmaceutical companies look at on-premise first
Most industries that consider self-hosting do it for personal data. Pharmaceutical companies have that concern too, but it is not the one that decides the architecture. What decides it is that a pharmaceutical company's most valuable asset is written down: the formulation, the process parameters that make a batch reproducible, the analytical methods, the stability data, the reasoning in a regulatory submission, the things that did not work and why.
That material is a trade secret rather than a regulated personal record. It has no expiry date, there is no breach notification that undoes its disclosure, and a competitor who sees it keeps the benefit permanently. Pasting a section of a process description into a consumer AI tool to get it rewritten is, in that light, a disclosure decision taken by whoever happened to be in a hurry.
The second driver is less obvious and often more persuasive internally: control over change. A hosted model can be updated by its vendor, and the same prompt can return a different answer next quarter. For a company whose quality system is built on knowing what changed, when, and who approved it, a system that silently changes underneath you is a governance problem before it is a technical one. A model you host is a version you pin, keep, and change deliberately.
What pharmaceutical teams actually run on it
The useful applications are unglamorous, which is a good sign. They sit around documents and search rather than anywhere near a decision about a product.
Finding what your own organisation already knows
Standard operating procedures, method documents, validation reports, deviation records, prior study reports and technical files accumulate across decades and systems. The common failure is not missing knowledge but unfindable knowledge, where work gets repeated because nobody knew it had been done. Retrieval-based search over your own document set, answering in sentences with a citation back to the source document, is the single most valuable thing most teams deploy first. Our guide to on-premise RAG systems covers how that is built.
Drafting support for documents a person then owns
First drafts of report sections, summaries of a long study report for an internal meeting, a plain-language restatement of a technical section. The output is a starting point an author edits and signs, never a document that goes anywhere as generated.
Triage and summarising of deviations and complaints
Grouping similar events, surfacing the earlier occurrences a reviewer should read, and drafting a summary for a human investigator. The judgement stays with the investigator; what changes is how long it takes them to see the pattern.
Supplier, specification and literature review
Comparing an incoming specification against your own, pulling the relevant passages out of a long technical dossier, and searching external literature you have licensed. All of it retrieval and summary, all of it checked.
Want to know whether your documents are usable as they are?
We will look at a sample of your SOPs and reports and tell you what a retrieval system could answer today, and what would need work first.
Book a Technical ReviewWhere we would tell you not to use it
This matters more here than in most sectors, and a supplier who will not give you this list is telling you something about how they build.
Nothing that constitutes a decision about product quality, batch disposition, patient safety or whether a deviation is acceptable. Those are decisions a qualified person makes and owns, and a model's output is not evidence. Nothing generated and submitted as a record without a named human author who has reviewed every line. Nothing that writes into a validated system directly. And nothing where the honest requirement is a deterministic calculation rather than a language model, because a model that is usually right is the wrong tool for arithmetic that must always be right.
The pattern that works is draft-and-approve, with the approval being real rather than a formality, and a clear record of who approved what. Our post on AI agent guardrails covers how permissions and approvals get designed, and reducing wrong answers covers what you can and cannot do about accuracy. The short version of the second one: wrong answers cannot be driven to zero, and anyone promising you an accuracy figure for your documents has not measured it on your documents.
How this differs from on-premise AI for healthcare
These get treated as one sector and they are two different buyers. A hospital's concern is patient data and care delivery: records, intake, clinical documentation, and a privacy obligation attached to an identifiable person. A pharmaceutical company's concern is intellectual property and the integrity of a documentation trail, with the personal data question usually confined to trial participants and handled by an existing framework the company already operates.
The architecture looks similar and the governance conversation is completely different, which is why the compliance questions below are not the ones a hospital asks. Our separate guide to on-premise AI for healthcare covers that side.
The questions your quality and IT functions will actually ask
Expect these, and expect the project to be judged on them rather than on a demo.
Which model version is running, where is it stored, and how do we know it has not changed. Who can see which documents, and does the system respect the access controls the source documents already have — because a retrieval system that ignores folder permissions quietly becomes a way to read things you should not. Where do prompts and outputs get logged, for how long, and who can read those logs. What happens when a document is superseded, so the system stops answering from a withdrawn version. How is the system itself assessed under your change control process, and does your quality function consider it a system requiring validation at all.
That last question is yours to answer, not your software supplier's. Your QA and regulatory colleagues should define what category this falls into under your own quality system before anyone buys hardware. This is not legal or regulatory advice and we do not give it; what we can do is build to the requirements your quality function sets. Nothing here names a statute, a regulator or a framework for that reason.
What it runs on
A GPU server inside your network, or in a private environment you control, running an open-weight model served through standard inference software, with your documents indexed into a vector store that also sits inside your network. Nothing leaves the perimeter, and the system works with the internet disconnected.
Model choice is a trade-off between capability and what your hardware can serve, and it is worth testing two or three on your own documents rather than taking a benchmark's word for it. Our posts on open-source models for business use, GPU servers and serving models in production cover the hardware and software side, and air-gapped AI deployment covers the stricter case where the machine has no network route out at all. For sites in Europe, on-premise AI in Europe covers the data-residency angle.
Rolling it out without disturbing regulated work
Start somewhere that is genuinely useful and carries no regulatory weight: document search for a research or technical team. It delivers value in weeks, it exposes the real state of your document estate, and nothing about it touches a record that matters. Let one group use it properly before anyone discusses a second use case.
Then do the unglamorous work the first group reveals. Expect to find superseded documents still in circulation, scanned files with no usable text, and three versions of the same procedure in different places. That is normal, and it is the reason to start small rather than a reason to stop. Our post on what an AI system needs from your business covers getting content into usable shape, and running a local model over confidential documents covers the handling details.
Name an owner per document area. The single best predictor of whether this still works a year from now is whether a person is responsible for each body of content being current, and the single most common cause of quiet failure is that nobody was.
Measuring whether it is working
Usage by team, questions asked that got no usable answer, and how often a user followed the citation to the source document. That last one is the honest signal: if people check the source, they are using it as a search tool, which is what it is good at. We publish no accuracy percentage for this, because a number measured on someone else's documents tells you nothing about yours, and we would rather build you a test set from your own real questions. Our on-premise versus cloud cost comparison covers the financial side without inventing a figure for your situation either.
Where to start
Pick one team and one body of documents they genuinely struggle to search. Write down ten real questions they ask. That list is a better specification than any requirements document, and it is what we would ask for first.
Inwizards has been building software since 2009, with teams in the US, UAE and India. On-premise AI covers how we deploy inside your network, AI agent development covers building something custom on top, and AI agents covers the workflow side once document search is working.